Shin wani a cikin iyalinka, wataƙila mahaifiyarka, mahaifinka, ko abokin rayuwarka, yana fama da cutar Alzheimer? To wataƙila ka san da kyau yadda take da wahala da zafi ga kowa a cikin iyali. Ba abu ne mai sauƙi ka kalli wannan cuta ba inda kake rasa tunaninka kowace rana ka manta da wanene kai. Don haka idan labari ya zo game da sabon magani ga wannan cuta, yana kawo babban bege da tambayoyi da yawa ga tunani. "Shin wannan yana aiki da gaske? Akwai wasu illoli? Wa zai iya amfani da wannan?" Dole ne akwai tambayoyi da yawa a cikin zuciyarka. Don haka bari mu yi magana game da komai a sarari kuma a sauƙaƙe a yau.
Menene wannan sabon maganin magana?
Sunan wannan sabon magani shine Lecanemab, kuma za a tallata shi da sunan Leqembi. Da farko, abu mafi mahimmanci da muke buƙatar fahimta shine cewa wannan ba maganin cutar Alzheimer bane. Duk da haka, yana yin wani babban abu. Wato, yana rage ci gaban cutar a farkon matakai . A taƙaice dai, yana jinkirta lalacewar ƙwaƙwalwar majiyyaci da ikon tunani.
Ana ba da wannan maganin a cikin jijiya bayan mako biyu. Ana saka maganin a hankali a cikin jiki, kamar yadda ake saka gishiri.
Yaya wannan maganin yake aiki?
Ka yi tunanin, idan muka kamu da cutar Alzheimer, wani abu mai mannewa da kamar shara yana taruwa tsakanin ƙwayoyin kwakwalwarmu. Muna kiran wannan amyloid. Wannan furotin da ake kira amyloid shine babban abin da ke haifar da lalacewar ƙwayoyin kwakwalwa da kuma asarar tunawa. Don haka abin da wannan sabon magani ke yi shi ne yana kai hari ga wannan furotin amyloid da ba a so a cikin kwakwalwa kuma yana cire shi. A wata ma'anar, wannan magani yana kai hari ga tushen cutar.
Wannan babban ci gaba ne a fannin likitancinmu. Domin yawancin magungunan da aka daɗe ana amfani da su sun sami damar shawo kan wasu daga cikin alamun cutar. Amma wannan maganin yana ƙoƙarin canza yanayin cutar.
Menene sakamakon da haɗarin hakan ke tattare da shi?
Kamar kowace magani, wannan magani yana da fa'idodi da rashin amfaninsa. Yana da mahimmanci mu san duka biyun.
Bincike ya nuna cewa marasa lafiya da suka sha wannan maganin na tsawon watanni 18 sun sami raguwar ƙwaƙwalwar ajiya da tunani da kashi 27% idan aka kwatanta da ƙungiyar placebo. Adadin amyloid a cikin kwakwalwa shi ma ya ragu sosai. Duk da cewa wannan na iya zama kamar ƙaramin kashi, babban abu ne cewa majiyyaci har yanzu zai iya ganin ƙaunatattunsa kuma ya yi aikinsu na wasu watanni.
Amma, muna kuma sane da haɗarin.
Babban haɗarin wannan maganin shine wata cuta da ake kira ARIA (matsalar hoton da ke da alaƙa da amyloid). A taƙaice dai, wannan na iya haifar da ƙananan kumburi ko ƙananan zubar jini a cikin kwakwalwa.Yana iya faruwa. A cikin bincike, an ruwaito wannan yanayin a cikin kusan kashi 14% na mutanen da suka sha maganin. Duk da haka, ga yawancin mutane, wannan ba ya haifar da manyan alamu. Duk da haka, ba kasafai yake zama mai tsanani ba.
Wannan haɗarin yana da yawa musamman ga marasa lafiya da ke shan magungunan rage radadi na jini . Saboda haka, yana da matuƙar muhimmanci majiyyaci ya gaya wa likita game da duk wasu magunguna da yake sha kafin ya fara wannan maganin.
Bugu da ƙari, illa kamar zazzaɓi, ciwon jiki, tashin zuciya, amai, da canje-canje a hawan jini na iya faruwa yayin allurar.
| Ƙwararru | Hadari da Fursunoni |
|---|---|
| Yana rage yawan mantuwa a farkon matakan cutar. | Haɗarin kumburin kwakwalwa da zubar jini (ARIA). |
| Yana cire sunadaran amyloid masu cutarwa daga kwakwalwa. | Dole ne a yi masa allura a cikin jijiya duk bayan mako biyu. |
| Yana kawo sabon bege na magance cutar. | Kasancewa mai tsada sosai a ƙasashen duniya. |
| Yana ba wa majiyyaci da iyali ƙarin lokaci. | Illolin da ke tattare da hakan kamar zazzaɓi da tashin zuciya na iya faruwa. |
Waye wannan maganin ya dace da shi?
Wannan shine mafi mahimmancin batu. Wannan maganin bai dace da kowane mai cutar Alzheimer ba.
- Kawai ga marasa lafiya da ke matakin farko: Wannan maganin ya fi tasiri ga marasa lafiya da ke matakin farko na cutar, ma'ana sun fara nuna alamun cutar. Yana da ƙarancin tasiri ga marasa lafiya da ke matakin ƙarshe na cutar, lokacin da cutar ta fi tsanani.
- Dole ne a tabbatar da Amyloid: Ya zama dole a tabbatar da cewa majiyyacin yana da tarin amyloid a cikin kwakwalwa ta hanyar gwaje-gwaje na musamman (duban PET ko huda lumbar).
- Ba don wasu nau'ikan ciwon hauka ba: Wannan maganin bai dace da wasu nau'ikan rashin tunawa ba, banda cutar Alzheimer (misali ciwon hauka na jijiyoyin jini).
Saboda haka, likitan jijiyoyi ne kawai zai iya yanke shawara ko wannan maganin ya dace da majiyyaci.
Farashi da yanayi a Sri Lanka
Farashin wannan maganin yana da tsada sosai. Kudin shekara-shekara a Amurka ya kai kimanin dala 26,500 (fiye da kuɗin Sri Lanka miliyan 8). Yana iya ɗaukar ɗan lokaci kafin a yi rijistar irin wannan sabon magani, na musamman kuma mai tsada a ƙasarmu kuma ya zama samuwa ga marasa lafiya na yau da kullun. Haka kuma, saboda tsadar magani, yana iya zama da wahala ga kowa ya same shi.
Duk da haka, wannan babban bege ne ga nan gaba. Tare da ci gaban kimiyya, muna fatan wata rana, irin waɗannan magunguna za a ƙara haɓaka su kuma za su kasance masu araha kuma masu sauƙin samu ga kowa.
Saƙon Ɗauka Gida
- Lecanemab ba magani bane ga cutar Alzheimer, amma magani ne da ke rage ci gaban cutar a farkon matakai .
- Wannan yana cire sunadaran amyloid masu cutarwa daga kwakwalwa, amma kuma yana da illa masu haɗari kamar kumburin kwakwalwa da zubar jini.
- Wannan maganin bai dace da kowa ba, musamman ga marasa lafiya da ke cikin matakin farko na cutar kuma an tabbatar suna da amyloid a cikin kwakwalwa.
- Wannan yana da tsada sosai, kuma samuwarsa a Sri Lanka a halin yanzu ba a tabbatar da shi ba.
- Idan wani a cikin iyalinka yana da cutar Alzheimer, tuntuɓi likitanka don tattauna duk wani sabon magani ko yanayin lafiya. Kada ka yanke shawara bisa ga abin da ka gani a intanet.
💬 Comments (0)
Har yanzu ba a buga sharhi ba. Ƙara bayanin ku anan a karon farko.
Ƙara sharhin ku